Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
ACADIA Pharmaceuticals (ACAD) Stock Forecast & Price Target
2,196 Followers
See the Price Targets and Ratings of:
ACAD Analyst Ratings
Strong Buy
12 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACAD Stock 12 Month Forecast
Average Price Target
$27.88
▲(56.10% Upside)
| Highest Price Target$39.00 | Average Price Target$27.88 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
TD Cowen
Reiterated
07/16/24
Morgan Stanley
Reiterated
07/12/24
Citi
Reiterated
07/09/24
BMO Capital
Initiated
06/26/24
RBC Capital
Reiterated
06/25/24
Oppenheimer
Reiterated
05/10/24
Stifel Nicolaus
Reiterated
05/10/24
H.C. Wainwright
Reiterated
05/09/24
Needham
Reiterated
05/09/24
Canaccord Genuity
Reiterated
05/09/24
Bank of America Securities
$30→$22
Hold
$22.00
(23.18% Upside)
Reiterated
05/09/24
Neutral Outlook on ACADIA Pharmaceuticals Amidst Revenue Miss and Revised Penetration Forecasts
JMP Securities
$39
Buy
$39.00
(118.37% Upside)
Reiterated
05/09/24
ACADIA Pharmaceuticals: Strong Sales and Promising Pipeline Justify Buy Rating
Robert W. Baird
$31→$28
Buy
$28.00
(56.77% Upside)
Assigned
05/08/24
Acadia Pharmaceuticals price target lowered to $28 from $31 at BairdAcadia Pharmaceuticals price target lowered to $28 from $31 at Baird
Leerink Partners
$33→$28
Buy
$28.00
(56.77% Upside)
Reiterated
05/08/24
Buy Rating for ACADIA Pharmaceuticals Based on Promising Drug Prospects and Financial Stability
Mizuho Securities
$25→$21
Hold
$21.00
(17.58% Upside)
Reiterated
05/08/24
Acadia Pharmaceuticals price target lowered to $21 from $25 at MizuhoAcadia Pharmaceuticals price target lowered to $21 from $25 at Mizuho
Best Analysts Covering ACADIA Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy ACAD and Sell After:
1 Month
xxx
Success Rate
13/26 ratings generated profit
Average Return
-3.53%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -3.53% per trade.
3 Months
xxx
Success Rate
15/24 ratings generated profit
Average Return
+6.70%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +6.70% per trade.
1 Year
Success Rate
14/24 ratings generated profit
Average Return
+10.05%
reiterated a buy rating 7 days ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +10.05% per trade.
2 Years
xxx
Success Rate
9/26 ratings generated profit
Average Return
-12.84%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 34.62% of your transactions generating a profit, with an average return of -12.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACAD Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
19
22
19
13
13
Buy
17
11
6
0
0
Hold
8
8
9
5
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
44
41
34
18
18
Each month's total comprises the sum of three months' worth of ratings.
ACAD Financial Forecast
ACAD Stock Forecast FAQ
What is ACAD’s average 12-month price target, according to analysts?
Based on analyst ratings, ACADIA Pharmaceuticals’s 12-month average price target is $27.88.
What is ACAD’s upside potential, based on the analysts’ average price target?
ACADIA Pharmaceuticals has 56.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACAD a Buy, Sell or Hold?
ACADIA Pharmaceuticals has a consensus rating of Strong Buy which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.
What is ACADIA Pharmaceuticals’s price target?
The average price target for ACADIA Pharmaceuticals is $27.88. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 56.10% Increase from the current price of $17.86.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 56.10% Increase from the current price of $17.86.
What do analysts say about ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of ACAD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.